Remote ischemic conditioning device developer CellAegis Devices has raised $3.1 million in a new round of equity financing, according to an SEC filing posted this week.
The Toronto-based company developed and proceeds the AutoRIC device, a portable automated device that provides ‘point of care’ delivery of remote ischemic conditioning, according to the company’s website.
The device has clearance in Canada and Europe, but is only cleared for investigational use in the US.
Funds in the round came from 5 unnamed sources, with the 1st sale recorded on March 1, according to the SEC filing.
CellAegis has not yet said how it plans to spend funds in the round.